ArticleProceedings (Baylor University. Medical Center)
Retroperitoneal malignant PEComa: a case report.
Article in Proceedings (Baylor University. Medical Center). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PEComa, or perivascular epithelioid cell tumor, is a distinctive mesenchymal neoplasm arising from perivascular epithelioid cells (PECs) that classically demonstrates a myomelanocytic immunophenotype. PEComas predominantly affect adults, with female predilection, and can occur at various anatomical sites, including the retroperitoneum, uterus, kidney, liver, and soft tissues. Most PEComas are considered benign and have an overall good prognosis. However, malignant PEComas are generally uncommon and tend to behave aggressively. In this clinical vignette, we present a 65-year-old woman with a malignant PEComa arising in the retroperitoneum with the development of metastatic disease, illustrating the importance of accurate diagnosis and potential treatment implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.